-
1
-
-
33746805519
-
Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents
-
Albaugh VL, Henry CR, Bello NT, Hajnal A, et al. (2006). Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents. Obesity (Silver Spring) 14, 36-51. (Pubitemid 46214773)
-
(2006)
Obesity
, vol.14
, Issue.1
, pp. 36-51
-
-
Albaugh, V.L.1
Henry, C.R.2
Bello, N.T.3
Hajnal, A.4
Lynch, S.L.5
Halle, B.6
Lynch, C.J.7
-
2
-
-
79952702945
-
Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis
-
Albaugh VL, Judson JG, She P, Lang CH, et al. (2010). Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis. Molecular Psychiatry 16, 569-581.
-
(2010)
Molecular Psychiatry
, vol.16
, pp. 569-581
-
-
Albaugh, V.L.1
Judson, J.G.2
She, P.3
Lang, C.H.4
-
3
-
-
0032751075
-
Antipsychotic-induced weight gain: A comprehensive research synthesis
-
Allison DB, Mentore JL, Heo M, Chandler LP, et al. (1999). Antipsychotic-induced weight gain: a comprehensive research synthesis. American Journal of Psychiatry 156, 1686-1696. (Pubitemid 29517559)
-
(1999)
American Journal of Psychiatry
, vol.156
, Issue.11
, pp. 1686-1696
-
-
Allison, D.B.1
Mentore, J.L.2
Heo, M.3
Chandler, L.P.4
Cappelleri, J.C.5
Infante, M.C.6
Weiden, P.J.7
-
4
-
-
1842844950
-
Consensus development conference on antipsychotic drugs and obesity and diabetes
-
American Diabetes Association, APA, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity
-
American Diabetes Association, APA, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. Journal of Clinical Psychiatry 65, 267-272.
-
(2004)
Journal of Clinical Psychiatry
, vol.65
, pp. 267-272
-
-
-
5
-
-
2342505730
-
An animal model of antipsychotic-induced weight gain
-
DOI 10.1016/j.bbr.2003.09.040, PII S0166432803003954
-
Arjona AA, Zhang SX, Adamson B, Wurtman RJ (2004). An animal model of antipsychotic-induced weight gain. Behavioural Brain Research 152, 121-127. (Pubitemid 38597070)
-
(2004)
Behavioural Brain Research
, vol.152
, Issue.1
, pp. 121-127
-
-
Arjona, A.A.1
Zhang, S.X.2
Adamson, B.3
Wurtman, R.J.4
-
6
-
-
33645471530
-
Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic
-
DOI 10.1177/0269881105058978
-
Ascher-Svanum H, Stensland MD, Kinon BJ, Tollefson GD (2005). Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic. Journal of Psychopharmacology 19(6 Suppl.), 110-117. (Pubitemid 44567865)
-
(2005)
Journal of Psychopharmacology
, vol.19
, Issue.SUPPL.
, pp. 110-117
-
-
Ascher-Svanum, H.1
Stensland, M.D.2
Kinon, B.J.3
Tollefson, G.D.4
-
7
-
-
33746886660
-
Association of initial antipsychotic response to clozapine and long-term weight gain
-
Bai YM, Lin CC, Chen JY, Lin CY, et al. (2006). Association of initial antipsychotic response to clozapine and long-term weight gain. American Journal of Psychiatry 163, 1276-1279.
-
(2006)
American Journal of Psychiatry
, vol.163
, pp. 1276-1279
-
-
Bai, Y.M.1
Lin, C.C.2
Chen, J.Y.3
Lin, C.Y.4
-
8
-
-
40949121112
-
Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions
-
DOI 10.1097/JCP.0b013e318166c4f7, PII 0000471420080400000002
-
Birkenaes AB, Birkeland KI, Engh JA, Faerden A, et al. (2008). Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions. Journal of Clinical Psychopharmacology 28, 132-137. (Pubitemid 351417117)
-
(2008)
Journal of Clinical Psychopharmacology
, vol.28
, Issue.2
, pp. 132-137
-
-
Birkenaes, A.B.1
Birkeland, K.I.2
Engh, J.A.3
Faerden, A.4
Jonsdottir, H.5
Ringen, P.A.6
Friis, S.7
Opjordsmoen, S.8
Andreassen, O.A.9
-
10
-
-
77956898286
-
Preclinical models of antipsychotic drug-induced metabolic side effects
-
Boyda HN, Tse L, Procyshyn RM, Honer WG, et al. (2010). Preclinical models of antipsychotic drug-induced metabolic side effects. Trends in Pharmacological Sciences 31, 484-497.
-
(2010)
Trends in Pharmacological Sciences
, vol.31
, pp. 484-497
-
-
Boyda, H.N.1
Tse, L.2
Procyshyn, R.M.3
Honer, W.G.4
-
11
-
-
23044461722
-
Expression and regulation of adiponectin and receptor in human and rat placenta
-
DOI 10.1210/jc.2004-0930
-
Caminos JE, Nogueiras R, Gallego R, Bravo S, et al. (2005). Expression and regulation of adiponectin and receptor in human and rat placenta. Journal of Clinical Endocrinology and Metabolism 90, 4276-4286. (Pubitemid 41058209)
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, Issue.7
, pp. 4276-4286
-
-
Caminos, J.E.1
Nogueiras, R.2
Gallego, R.3
Bravo, S.4
Tovar, S.5
Garcia-Caballero, T.6
Casanueva, F.F.7
Dieguez, C.8
-
12
-
-
60249097928
-
Insulin resistance and secretion in vivo: Effects of different antipsychotics in an animal model
-
Chintoh AF, Mann SW, Lam L, Giacca A, et al. (2009). Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model. Schizophrenia Research 108, 127-133.
-
(2009)
Schizophrenia Research
, vol.108
, pp. 127-133
-
-
Chintoh, A.F.1
Mann, S.W.2
Lam, L.3
Giacca, A.4
-
13
-
-
53849146057
-
Olanzapine (LY170053, 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3- b][1,5] benzodiazepine), but not the novel atypical antipsychotic ST2472 (9-piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), chronic administration induces weight gain, hyperphagia, and metabolic dysregulation in mice
-
Coccurello R, Caprioli A, Conti R, Ghirardi O, et al. (2008). Olanzapine (LY170053, 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine), but not the novel atypical antipsychotic ST2472 (9-piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), chronic administration induces weight gain, hyperphagia, and metabolic dysregulation in mice. Journal of Pharmacology and Experimental Therapeutics 326, 905-911.
-
(2008)
Journal of Pharmacology and Experimental Therapeutics
, vol.326
, pp. 905-911
-
-
Coccurello, R.1
Caprioli, A.2
Conti, R.3
Ghirardi, O.4
-
14
-
-
84978743958
-
Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states
-
Colton CW, Manderscheid RW (2006). Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Preventing Chronic Disease 3, A42.
-
(2006)
Preventing Chronic Disease
, vol.3
-
-
Colton, C.W.1
Manderscheid, R.W.2
-
15
-
-
26644458378
-
A parametric analysis of olanzapine-induced weight gain in female rats
-
DOI 10.1007/s00213-005-2224-4
-
Cooper GD, Pickavance LC, Wilding JP, Halford JC, et al. (2005). A parametric analysis of olanzapine-induced weight gain in female rats. Psychopharmacology (Berlin) 181, 80-89. (Pubitemid 41440918)
-
(2005)
Psychopharmacology
, vol.181
, Issue.1
, pp. 80-89
-
-
Cooper, G.D.1
Pickavance, L.C.2
Wilding, J.P.H.3
Halford, J.C.G.4
Goudie, A.J.5
-
16
-
-
34447575781
-
Effects of olanzapine in male rats: Enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities
-
DOI 10.1177/0269881106069637
-
Cooper GD, Pickavance LC, Wilding JP, Harrold JA, et al. (2007). Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities. Journal of Psychopharmacology 21, 405-413. (Pubitemid 47077303)
-
(2007)
Journal of Psychopharmacology
, vol.21
, Issue.4
, pp. 405-413
-
-
Cooper, G.D.1
Pickavance, L.C.2
Wilding, J.P.H.3
Harrold, J.A.4
Halford, J.C.G.5
Goudie, A.J.6
-
17
-
-
55949118484
-
Abdominal obesity: The cholesterol of the 21st century?
-
Despres JP, Arsenault BJ, Cote M, Cartier A, et al. (2008). Abdominal obesity: the cholesterol of the 21st century? Canadian Journal of Cardiology 24(Suppl. D), 7D-12D.
-
(2008)
Canadian Journal of Cardiology
, vol.24
, Issue.SUPPL. D
-
-
Despres, J.P.1
Arsenault, B.J.2
Cote, M.3
Cartier, A.4
-
19
-
-
27144450193
-
Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: A novel mechanism of action?
-
DOI 10.1038/sj.tpj.6500323, PII 6500323
-
Ferno J, Raeder MB, Vik-Mo AO, Skrede S, et al. (2005). Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action? Pharmacogenomics Journal 5, 298-304. (Pubitemid 41486229)
-
(2005)
Pharmacogenomics Journal
, vol.5
, Issue.5
, pp. 298-304
-
-
Ferno, J.1
Raeder, M.B.2
Vik-Mo, A.O.3
Skrede, S.4
Glambek, M.5
Tronstad, K.-J.6
Breilid, H.7
Lovlie, R.8
Berge, R.K.9
Stansberg, C.10
Steen, V.M.11
-
20
-
-
33750980390
-
Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: Marked differences between various antipsychotic drugs
-
Ferno J, Skrede S, Vik-Mo AO, Havik B, et al. (2006). Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs. BMC Neuroscience 7, 69.
-
(2006)
BMC Neuroscience
, vol.7
, pp. 69
-
-
Ferno, J.1
Skrede, S.2
Vik-Mo, A.O.3
Havik, B.4
-
21
-
-
79958694588
-
Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation
-
Ferno J, Varela L, Skrede S, Vazquez MJ, et al. (2011). Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation. PLoS One 6, e20571.
-
(2011)
PLoS One
, vol.6
-
-
Ferno, J.1
Varela, L.2
Skrede, S.3
Vazquez, M.J.4
-
22
-
-
60449111934
-
Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver
-
Ferno J, Vik-Mo AO, Jassim G, Havik B, et al. (2009). Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver. Psychopharmacology (Berlin) 203, 73-84.
-
(2009)
Psychopharmacology (Berlin)
, vol.203
, pp. 73-84
-
-
Ferno, J.1
Vik-Mo, A.O.2
Jassim, G.3
Havik, B.4
-
23
-
-
67650564158
-
Depot-specific effects of the PPAR{gamma} agonist rosiglitazone on adipose tissue glucose uptake and metabolism
-
Festuccia WT, Blanchard PG, Turcotte V, Laplante M, et al. (2009). Depot-specific effects of the PPAR{gamma} agonist rosiglitazone on adipose tissue glucose uptake and metabolism. Journal of Lipid Research 50, 1185-1194.
-
(2009)
Journal of Lipid Research
, vol.50
, pp. 1185-1194
-
-
Festuccia, W.T.1
Blanchard, P.G.2
Turcotte, V.3
Laplante, M.4
-
25
-
-
42749087700
-
Short-and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression
-
Han M, Deng C, Burne TH, Newell KA, et al. (2008). Short-and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression. Psychoneuroendocrinology 33, 569-580.
-
(2008)
Psychoneuroendocrinology
, vol.33
, pp. 569-580
-
-
Han, M.1
Deng, C.2
Burne, T.H.3
Newell, K.A.4
-
26
-
-
0034791356
-
Clozapine: Diabetes mellitus, weight gain, and lipid abnormalities
-
Henderson DC (2001). Clozapine: diabetes mellitus, weight gain, and lipid abnormalities. Journal of Clinical Psychiatry 62(Suppl. 23), 39-44. (Pubitemid 32952693)
-
(2001)
Journal of Clinical Psychiatry
, vol.62
, Issue.SUPPL. 23
, pp. 39-44
-
-
Henderson, D.C.1
-
27
-
-
67649313808
-
Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients
-
Henderson DC, Fan X, Copeland PM, Sharma B, et al. (2009). Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients. Journal of Clinical Psychopharmacology 29, 165-169.
-
(2009)
Journal of Clinical Psychopharmacology
, vol.29
, pp. 165-169
-
-
Henderson, D.C.1
Fan, X.2
Copeland, P.M.3
Sharma, B.4
-
28
-
-
34748846290
-
Metabolomic mapping of atypical antipsychotic effects in schizophrenia
-
DOI 10.1038/sj.mp.4002000, PII 4002000
-
Kaddurah-Daouk R, McEvoy J, Baillie RA, Lee D, et al. (2007). Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Molecular Psychiatry 12, 934-945. (Pubitemid 47482696)
-
(2007)
Molecular Psychiatry
, vol.12
, Issue.10
, pp. 934-945
-
-
Kaddurah-Daouk, R.1
McEvoy, J.2
Baillie, R.A.3
Lee, D.4
Yao, J.K.5
Doraiswamy, P.M.6
Krishnan, K.R.R.7
-
29
-
-
26844446471
-
Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats
-
DOI 10.1007/s00213-005-0081-9
-
Kalinichev M, Rourke C, Daniels AJ, Grizzle MK, et al. (2005). Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs. olanzapine on body weight and prolactin secretion in female rats. Psychopharmacology (Berlin) 182, 220-231. (Pubitemid 41464615)
-
(2005)
Psychopharmacology
, vol.182
, Issue.2
, pp. 220-231
-
-
Kalinichev, M.1
Rourke, C.2
Daniels, A.J.3
Grizzle, M.K.4
Britt, C.S.5
Ignar, D.M.6
Jones, D.N.C.7
-
31
-
-
77953233342
-
Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes
-
Lauressergues E, Staels B, Valeille K, Majd Z, et al. (2010). Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes. Naunyn Schmiedeberg's Archives of Pharmacology 381, 427-439.
-
(2010)
Naunyn Schmiedeberg's Archives of Pharmacology
, vol.381
, pp. 427-439
-
-
Lauressergues, E.1
Staels, B.2
Valeille, K.3
Majd, Z.4
-
32
-
-
58049157203
-
Second-generation vs. first-generation antipsychotic drugs for schizophrenia: A meta-analysis
-
Leucht S, Corves C, Arbter D, Engel RR, et al. (2009). Second-generation vs. first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373, 31-41.
-
(2009)
Lancet
, vol.373
, pp. 31-41
-
-
Leucht, S.1
Corves, C.2
Arbter, D.3
Engel, R.R.4
-
33
-
-
25144456112
-
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
-
DOI 10.1056/NEJMoa051688
-
Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, et al. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 353, 1209-1223. (Pubitemid 41345943)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.12
, pp. 1209-1223
-
-
Lieberman, J.A.1
Scott Stroup, T.2
McEvoy, J.P.3
Swartz, M.S.4
Rosenheck, R.A.5
Perkins, D.O.6
Keefe, R.S.E.7
Davis, S.M.8
Davis, C.E.9
Lebowitz, B.D.10
Severe, J.11
Hsiao, J.K.12
-
34
-
-
77956431307
-
Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance
-
Lopez M, Varela L, Vazquez MJ, Rodriguez-Cuenca S, et al. (2010). Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nature Medicine 16, 1001-1008.
-
(2010)
Nature Medicine
, vol.16
, pp. 1001-1008
-
-
Lopez, M.1
Varela, L.2
Vazquez, M.J.3
Rodriguez-Cuenca, S.4
-
35
-
-
79956088603
-
Atypical antipsychotic medications increase postprandial triglyceride and glucose levels in male rats: Relationship with stearoyl-CoA desaturase activity
-
McNamara RK, Jandacek R, Rider T, Tso P, et al. (2011). Atypical antipsychotic medications increase postprandial triglyceride and glucose levels in male rats: relationship with stearoyl-CoA desaturase activity. Schizophrenia Research 129, 66-73.
-
(2011)
Schizophrenia Research
, vol.129
, pp. 66-73
-
-
McNamara, R.K.1
Jandacek, R.2
Rider, T.3
Tso, P.4
-
36
-
-
0036252327
-
A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: Metabolic outcomes after 1 year
-
Meyer JM (2002). A retrospective comparison of weight, lipid, and glucose changes between risperidone-and olanzapine-treated inpatients: metabolic outcomes after 1 year. Journal of Clinical Psychiatry 63, 425-433. (Pubitemid 34507221)
-
(2002)
Journal of Clinical Psychiatry
, vol.63
, Issue.5
, pp. 425-433
-
-
Meyer, J.M.1
-
37
-
-
33744992710
-
Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration
-
DOI 10.1016/j.appet.2006.01.008, PII S0195666306000092
-
Minet-Ringuet J, Even PC, Goubern M, Tome D, et al. (2006a). Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration. Appetite 46, 254-262. (Pubitemid 43867820)
-
(2006)
Appetite
, vol.46
, Issue.3
, pp. 254-262
-
-
Minet-Ringuet, J.1
Even, P.C.2
Goubern, M.3
Tome, D.4
Beaurepaire, R.D.5
-
38
-
-
33746912797
-
A model for antipsychotic-induced obesity in the male rat
-
DOI 10.1007/s00213-006-0433-0
-
Minet-Ringuet J, Even PC, Lacroix M, Tome D, et al. (2006b). A model for antipsychotic-induced obesity in the male rat. Psychopharmacology (Berlin) 187, 447-454. (Pubitemid 44200516)
-
(2006)
Psychopharmacology
, vol.187
, Issue.4
, pp. 447-454
-
-
Minet-Ringuet, J.1
Even, P.C.2
Lacroix, M.3
Tome, D.4
De Beaurepaire, R.5
-
39
-
-
34249330985
-
Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment
-
DOI 10.1038/sj.mp.4001948, PII 4001948
-
Minet-Ringuet J, Even PC, Valet P, Carpene C, et al. (2007). Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment. Molecular Psychiatry 12, 562-571. (Pubitemid 46816768)
-
(2007)
Molecular Psychiatry
, vol.12
, Issue.6
, pp. 562-571
-
-
Minet-Ringuet, J.1
Even, P.C.2
Valet, P.3
Carpene, C.4
Visentin, V.5
Prevot, D.6
Daviaud, D.7
Quignard-Boulange, A.8
Tome, D.9
De Beaurepaire, R.10
-
40
-
-
56149105939
-
Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole vs. olanzapine
-
Newcomer JW, Meyer JM, Baker RA, Eudicone JM, et al. (2008). Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole vs. olanzapine. Schizophrenia Research 106, 300-307.
-
(2008)
Schizophrenia Research
, vol.106
, pp. 300-307
-
-
Newcomer, J.W.1
Meyer, J.M.2
Baker, R.A.3
Eudicone, J.M.4
-
41
-
-
0037143752
-
Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity
-
DOI 10.1073/pnas.132384699
-
Ntambi JM, Miyazaki M, Stoehr JP, Lan H, et al. (2002). Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proceedings of the National Academy of Sciences USA 99, 11482-11486. (Pubitemid 34920951)
-
(2002)
Proceedings of the National Academy of Sciences of the United States of America
, vol.99
, Issue.17
, pp. 11482-11486
-
-
Ntambi, J.M.1
Miyazaki, M.2
Stoehr, J.P.3
Lan, H.4
Kendziorski, C.M.5
Yandell, B.S.6
Song, Y.7
Cohen, P.8
Friedman, J.M.9
Attie, A.D.10
-
42
-
-
34848827473
-
Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment
-
Procyshyn RM, Wasan KM, Thornton AE, Barr AM, et al. (2007). Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment. Journal of Psychiatry and Neuroscience 32, 331-338. (Pubitemid 47492758)
-
(2007)
Journal of Psychiatry and Neuroscience
, vol.32
, Issue.5
, pp. 331-338
-
-
Procyshyn, R.M.1
Wasan, K.M.2
Thornton, A.E.3
Barr, A.M.4
Chen, E.Y.H.5
Pomarol-Clotet, E.6
Stip, E.7
Williams, R.8
MacEwan, G.W.9
Birmingham, C.L.10
Honer, W.G.11
-
43
-
-
33748328048
-
SREBP activation by antipsychotic- and antidepressant-drugs in cultured human liver cells: Relevance for metabolic side-effects?
-
DOI 10.1007/s11010-006-9160-4
-
Raeder MB, Ferno J, Vik-Mo AO, Steen VM (2006). SREBP activation by antipsychotic-and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects? Molecular and Cellular Biochemistry 289, 167-173. (Pubitemid 44322486)
-
(2006)
Molecular and Cellular Biochemistry
, vol.289
, Issue.1-2
, pp. 167-173
-
-
Raeder, M.B.1
Ferno, J.2
Vik-Mo, A.O.3
Steen, V.M.4
-
44
-
-
0036007024
-
C/EBPα induces adipogenesis through PPARγ: A unified pathway
-
DOI 10.1101/gad.948702
-
Rosen ED, Hsu CH, Wang X, Sakai S, et al. (2002). C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes and Development 16, 22-26. (Pubitemid 34049634)
-
(2002)
Genes and Development
, vol.16
, Issue.1
, pp. 22-26
-
-
Rosen, E.D.1
Hsu, C.-H.2
Wang, X.3
Sakai, S.4
Freeman, M.W.5
Gonzalez, F.J.6
Spiegelman, B.M.7
-
45
-
-
0033990048
-
Primer3 on the WWW for general users and for biologist programmers
-
Rozen S, Skaletsky H (2000). Primer3 on the WWW for general users and for biologist programmers. Methods in Molecular Biology 132, 365-386.
-
(2000)
Methods in Molecular Biology
, vol.132
, pp. 365-386
-
-
Rozen, S.1
Skaletsky, H.2
-
46
-
-
77957923642
-
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
-
Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, et al. (2010). Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophrenia Research 123, 225-233.
-
(2010)
Schizophrenia Research
, vol.123
, pp. 225-233
-
-
Rummel-Kluge, C.1
Komossa, K.2
Schwarz, S.3
Hunger, H.4
-
47
-
-
34548190628
-
SREBP-1-independent regulation of lipogenic gene expression in adipocytes
-
DOI 10.1194/jlr.M700033-JLR200
-
Sekiya M, Yahagi N, Matsuzaka T, Takeuchi Y, et al. (2007). SREBP-1-independent regulation of lipogenic gene expression in adipocytes. Journal of Lipid Research 48, 1581-1591. (Pubitemid 47312019)
-
(2007)
Journal of Lipid Research
, vol.48
, Issue.7
, pp. 1581-1591
-
-
Sekiya, M.1
Yahagi, N.2
Matsuzaka, T.3
Takeuchi, Y.4
Nakagawa, Y.5
Takahashi, H.6
Okazaki, H.7
Iizuka, Y.8
Ohashi, K.9
Gotoda, T.10
Ishibashi, S.11
Nagai, R.12
Yamazaki, T.13
Kadowaki, T.14
Yamada, N.15
Osuga, J.-I.16
Shimano, H.17
-
48
-
-
0034804783
-
Sterol regulatory element-binding proteins (SREBPs): Transcriptional regulators of lipid synthetic genes
-
DOI 10.1016/S0163-7827(01)00010-8, PII S0163782701000108
-
Shimano H (2001). Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Progress in Lipid Research 40, 439-452. (Pubitemid 32929966)
-
(2001)
Progress in Lipid Research
, vol.40
, Issue.6
, pp. 439-452
-
-
Shimano, H.1
-
49
-
-
0032532152
-
Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: Model for congenital generalized lipodystrophy
-
Shimomura I, Hammer RE, Richardson JA, Ikemoto S, et al. (1998). Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes and Development 12, 3182-3194. (Pubitemid 28496263)
-
(1998)
Genes and Development
, vol.12
, Issue.20
, pp. 3182-3194
-
-
Shimomura, I.1
Hammer, R.E.2
Richardson, J.A.3
Ikemoto, S.4
Bashmakov, Y.5
Goldstein, J.L.6
Brown, M.S.7
-
50
-
-
57949084753
-
The role of thermogenesis in antipsychotic drug-induced weight gain
-
Stefanidis A, Verty AN, Allen AM, Owens NC, et al. (2009). The role of thermogenesis in antipsychotic drug-induced weight gain. Obesity (Silver Spring) 17, 16-24.
-
(2009)
Obesity (Silver Spring)
, vol.17
, pp. 16-24
-
-
Stefanidis, A.1
Verty, A.N.2
Allen, A.M.3
Owens, N.C.4
-
51
-
-
75349098410
-
Aripiprazole in schizophrenia and schizoaffective disorder: A review
-
Stip E, Tourjman V (2010). Aripiprazole in schizophrenia and schizoaffective disorder: a review. Clinical Therapeutics 32 (Suppl. 1), S3-20.
-
(2010)
Clinical Therapeutics
, vol.32
, Issue.SUPPL. 1
-
-
Stip, E.1
Tourjman, V.2
-
52
-
-
68949172254
-
11-year follow-up of mortality in patients with schizophrenia: A population-based cohort study (FIN11 study
-
Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, et al. (2009). 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 374, 620-627.
-
(2009)
Lancet
, vol.374
, pp. 620-627
-
-
Tiihonen, J.1
Lonnqvist, J.2
Wahlbeck, K.3
Klaukka, T.4
-
53
-
-
46449138724
-
Increased expression of lipid biosynthesis genes in peripheral blood cells of olanzapine-treated patients
-
DOI 10.1017/S1461145708008468, PII S1461145708008468
-
Vik-Mo AO, Birkenaes AB, Ferno J, Jonsdottir H, et al. (2008). Increased expression of lipid biosynthesis genes in peripheral blood cells of olanzapine-treated patients. International Journal of Neuropsychopharmacology 11, 679-684. (Pubitemid 351931824)
-
(2008)
International Journal of Neuropsychopharmacology
, vol.11
, Issue.5
, pp. 679-684
-
-
Vik-Mo, A.O.1
Birkenaes, A.B.2
Ferno, J.3
Jonsdottir, H.4
Andreassen, O.A.5
Steen, V.M.6
-
54
-
-
34548208771
-
Olanzapine induces SREBP-1-related adipogenesis in 3T3-L1 cells
-
Yang LH, Chen TM, Yu ST, Chen YH (2007). Olanzapine induces SREBP-1-related adipogenesis in 3T3-L1 cells. Pharmacological Research 56, 202-208.
-
(2007)
Pharmacological Research
, vol.56
, pp. 202-208
-
-
Yang, L.H.1
Chen, T.M.2
Yu, S.T.3
Chen, Y.H.4
|